-
New drugs that have received conditional approval of marketing in China
Erxiao
September 12, 2018
New drugs that have received conditional approval of marketing in China
-
“Conditional Approval” Contributing a Great Share in the New Drug Marketing Acceleration in China
Erxiao
September 12, 2018
Several blockbuster drugs such as 9-valent HPV vaccine and Pyrotinib Maleate Tablets have recently been fast approved for marketing in China...
-
Amgen Submits Supplemental New Drug Application for Kyprolis
americanpharmaceuticalreview
August 28, 2018
Amgen announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) to expand the Prescribing Information for Kyprolis (carfilzomib) to include a once-weekly dosing option in combination with dexamet
-
Breakthrough! Phase III Clinical Study of the Chinese New Drug for Alzheimer's Disease Met the Endpoint and is Waiting for Marketing
Muzi
August 02, 2018
This can be called a “cardiac stimulant” to the AD drug market that has long been sluggish.
-
Promising new drug slows Parkinson's progression in mice
pharmafile
July 06, 2018
According to investigators of the study, which has been published in the journal Nature Medicine, the compound prevents the process through which astrocytes – star shaped cells that assist neurons in communicating – are converted into aggressive ‘activat
-
Analysis of New Drug R&D Strategies: Advantages of First-to-Market Drugs Shrinking while Latecomer me-better Drugs Surpassing
Mr. Nanguo
June 15, 2018
In the new drug development, pursuing the marketing of the first product of its variety is always the highest goal of pharmaceutical enterprises
-
New drug hope for rare bone cancer patients
worldpharmanews
October 13, 2017
In the largest genomics study of chordoma to date, published today in Nature Communications, scientists show that a group of chordoma patients have mutations in genes that are the target of existing drugs, known as PI3K inhibitors.
-
China accelerates new drug approvals
biospectrumasia
October 10, 2017
The move is also a growth opportunity for international and local drugmakers in the world’s second biggest pharmaceutical market.